UNSPSC 51385612: Diethylamine salicylate

This classification denotes an anti-inflammatory with the molecular formula C11H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V7PT38BJU, chemically known as 2-carboxyphenolate;diethylazanium but generally known as acetylsalicylic acid, which bears US NIH Compound Identifier 54678495. European Medicines Agency schedules diethylamine salicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB43350 and SUB13573MIG.

As of Q4 2014, DIETHYLAMINE SALICYLATE remains the US FDA Preferred Term for this commodity. SMILES: CC[NH2+]CC.C1=CC=C(C(=C1)C(=O)O)[O-].

UNSPSC 51385612 Diethylamine salicylate is a Commodity code under which state and local governments rarely solicit procurement, based on recent contracting activity. The three most recent opportunities posted under this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives, and generic multi-source pharmaceuticals and OTC products — none of which map directly to diethylamine salicylate, a chemical compound with limited application in state and local government purchasing. The disconnect between the code's nominal scope and the work actually being tagged to it suggests the code sees minimal or mislabeled procurement activity at the state and local level, making it unsuitable for active pursuit.

Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) to establish contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities. Recent opportunities cluster around health department and human services procurement in Texas and Minnesota, with isolated county-level activity in Florida. The code shows no consistent or substantial state and local contracting momentum for diethylamine salicylate specifically, warranting a skip recommendation unless your firm has a direct relationship to one of the mislabeled solicitations above.